QUETZAL ENERGY LTD.

Inactive Instrument

Insiders Quetzal Energy Ltd. Toronto S.E.

Equities

QEI

CA74839M1032

End-of-day quote Toronto S.E. Other stock markets
- ^CAD	-

2021	Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107	MT
2021	Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Kalytera Therapeutics, Inc. will Change its Name to Claritas Pharmaceuticals, Inc	12/04/21	CI
Claritas Pharmaceuticals, Inc. Appoints Perenlei Enkhbaatar as an Independent Member of the Company’s Board of Directors, Effective Immediately	26/03/21	CI
Claritas Pharmaceuticals, Inc. Announces Board Changes	18/03/21	CI
Claritas (Formerly Kalytera Therapeutics, Inc.) Announces Addition of Professor Salvatore Cuzzocrea to the Board of Directors	05/03/21	CI
Kalytera Announces Changes to Board of Directors	21/06/19	CI
Kalytera Announces Formation of Strategic and Scientific Advisory Board	15/05/18	CI
Kalytera Therapeutics, Inc. Appoints Gary Leong as Member of the Audit Committee	31/05/17	CI
Kalytera Therapeutics, Inc. Announces Executive Changes	26/05/17	CI
Kalytera Therapeutics, Inc. Appoints Pini Ben-Elazar to Board of Directors	17/03/17	CI
Kalytera Therapeutics, Inc. Appoints Dr. Andrew Salzman as Chief Medical Officer	23/08/16	CI
Kalytera Therapeutics Appoints Dr. Stuart Silverman as Senior Vice President of Medical Affairs	27/06/16	CI
Kalytera Therapeutics, Inc. Appoints Robert S. Langer to the Scientific Advisory Board	23/06/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer